Adoptive Immunotherapy Against Ovarian Cancer

This review article was published by the Journal of Ovarian Research in May of 2016. Download the Publication The abstract: The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find … Continue reading Adoptive Immunotherapy Against Ovarian Cancer